Cell Therapy Manufacturer Leases Space in Woburn
An Israeli biotech firm that treats rare pediatric diseases is relocating from Cambridge’s Kendall Square to a Woburn facility as it prepares to begin cell therapy manufacturing.
Most Popular | Most Recent
- Unlocking Homeownership: Webster First FCU’s Guide to Mortgage Solutions
- Related Beal Closes on Financing for Vertex Lab Project
- Federal Reserve Declines to Cut Interest Rates, Cites Continued Inflation
- Boylston Street Property Trades for $39.1M
- Guv Appeals to Biz to Join Housing Fight
- Berkshire Bank to Close 3 CT Branches
- The B&T Daily: May 1, 2024
- Funding Secured for Multifamily Development in Wakefield
- Powell Likely to Signal Lower Inflation Is Needed Before Fed Will Cut Rates
- Wakefield Turns Down MBTA Communities Zoning
- Hot Property: Hanover Crossing 2 views
- Margaret Briggs 1 view
- Rosengren Joins Calls for Fed Stimulus Drawdown 1 view
- Berardi Elected REBA President 1 view
- Reading Cooperative Up 7 Percent In ’08 1 view
- Baker-Polito Administration Successfully Preserves Affordable Housing 1 view
- This Month in History: The End of the ‘Plywood Palace’ 1 view
- Amenities Take Center Stage in Boston’s Newest Office Tower 1 view
- Q2 Revenue Up for Five Star 1 view
- Second Roxse Homes Employee Sentenced For Rental Scheme 1 view